Axsome Therapeutics
Axsome Therapeutics is seeking a Specialist, Quality Control to support the management of analytical data and stability studies for its commercial drug portfolio. This role involves ensuring compliance with GMP principles, collaborating with cross-functional groups, and contributing to various Quality Control activities. The position is based at the company's New York City headquarters with an on-site requirement of at least three days per week.
Headquarters
New York, New York, United States
Company Size
201-500 employees
Founded
2012
Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Its pipeline and commercial programs include candidates such as AXS-05, AXS-12 and AXS-14, addressing disorders including major depressive disorder, Alzheimer’s disease agitation, migraine, narcolepsy and fibromyalgia. Axsome emphasizes innovative mechanisms of action and rigorous clinical development to deliver meaningful improvements in patient outcomes. The company is headquartered in New York City and advances programs through regulatory engagement and commercialization efforts.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Axsome Therapeutics.
37% above the average for this role
Axsome Therapeutics, Inc. (AXSM): A Bull Case Theory
2 weeks ago